ALLIANCE-A032302-ASPIRE
Phase III
OPEN TO ACCRUAL
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
NRG-GU008-INNOVATE
Phase III
OPEN TO ACCRUAL
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy